An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users administering substances of unknown origin.
Several professionals stated the demand for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and consumer laws, risking fines, prosecution or prison.
Platform Response and Content Elimination
According to the social media company, the service has removed violative material and prohibited related keywords and query recommendations. The organization stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of weight loss, positive testimonials and detailed guides for preparing or injecting at home.
Within minutes of entering one community, a vendor posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Item Details and Costs
Within these communities, posts display dark colored packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the research behind retatrutide is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may expose users to possibly significant health risks”.
